These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8610405)

  • 1. T cell recognition of xeno-MHC peptides during concordant xenograft rejection.
    Murphy B; Auchincloss H; Carpenter CB; Sayegh MH
    Transplantation; 1996 Apr; 61(8):1133-7. PubMed ID: 8610405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of allo-recognition. Recognition by in vivo-primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells.
    Watschinger B; Gallon L; Carpenter CB; Sayegh MH
    Transplantation; 1994 Feb; 57(4):572-6. PubMed ID: 8116044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The indirect pathway of allorecognition. The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression.
    Gallon L; Watschinger B; Murphy B; Akalin E; Sayegh MH; Carpenter CB
    Transplantation; 1995 Feb; 59(4):612-6. PubMed ID: 7878766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
    Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
    Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of indirect allorecognition in graft rejection: class II MHC allopeptide-specific T cell clones transfer delayed-type hypersensitivity responses in vivo.
    Chen W; Murphy B; Waaga AM; Willett TA; Russell ME; Khoury SJ; Sayegh MH
    Transplantation; 1996 Sep; 62(6):705-10. PubMed ID: 8824464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of acquired thymic unresponsiveness to renal allografts. Thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy.
    Sayegh MH; Perico N; Gallon L; Imberti O; Hancock WW; Remuzzi G; Carpenter CB
    Transplantation; 1994 Jul; 58(2):125-32. PubMed ID: 8042230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of indirect allorecognition: characterization of MHC class II allopeptide-specific T helper cell clones from animals undergoing acute allograft rejection.
    Waaga AM; Chandraker A; Spadafora-Ferreira M; Iyengar AR; Khoury SJ; Carpenter CB; Sayegh MH
    Transplantation; 1998 Apr; 65(7):876-83. PubMed ID: 9565089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The degree of phylogenetic disparity of islet grafts dictates the reliance on indirect CD4 T-cell antigen recognition for rejection.
    Rayat GR; Johnson ZA; Beilke JN; Korbutt GS; Rajotte RV; Gill RG
    Diabetes; 2003 Jun; 52(6):1433-40. PubMed ID: 12765954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymic recognition of class II major histocompatibility complex allopeptides induces donor-specific unresponsiveness to renal allografts.
    Sayegh MH; Perico N; Imberti O; Hancock WW; Carpenter CB; Remuzzi G
    Transplantation; 1993 Aug; 56(2):461-5. PubMed ID: 7689263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
    Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
    J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of indirect recognition mediated by CD4+ T cells leads to prolonged cardiac xenograft survival.
    Singh NP; Guo L; Que X; Shirwan H
    Xenotransplantation; 2004 Jan; 11(1):33-42. PubMed ID: 14962291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute rejection of orthotopic corneal xenografts in mice depends on CD4(+) T cells and self-antigen-presenting cells.
    Tanaka K; Sonoda K; Streilein JW
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2878-84. PubMed ID: 11687532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 T cells mediate cardiac xenograft rejection via host MHC Class II.
    Plenter RJ; Grazia TJ; Doan AN; Gill RG; Pietra BA
    J Heart Lung Transplant; 2012 Sep; 31(9):1018-24. PubMed ID: 22789136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically engineered grafts to study xenoimmunity: a role for indirect antigen presentation in the destruction of major histocompatibility complex antigen deficient xenografts.
    Markmann JF; Campos L; Bhandoola A; Kim JI; Desai NM; Bassiri H; Claytor BR; Barker CF
    Surgery; 1994 Aug; 116(2):242-8; discussion 248-9. PubMed ID: 8047991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited T cell response to donor MHC peptides during allograft rejection. Implications for selective immune therapy in transplantation.
    Benichou G; Fedoseyeva E; Lehmann PV; Olson CA; Geysen HM; McMillan M; Sercarz EE
    J Immunol; 1994 Aug; 153(3):938-45. PubMed ID: 7517977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II.
    Pietra BA; Wiseman A; Bolwerk A; Rizeq M; Gill RG
    J Clin Invest; 2000 Oct; 106(8):1003-10. PubMed ID: 11032860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat.
    Sayegh MH; Khoury SJ; Hancock WW; Weiner HL; Carpenter CB
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7762-6. PubMed ID: 1502196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indirect T cell allorecognition and alloantibody-mediated rejection of MHC class I-disparate heart grafts.
    Pettigrew GJ; Lovegrove E; Bradley JA; Maclean J; Bolton EM
    J Immunol; 1998 Aug; 161(3):1292-8. PubMed ID: 9686590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts.
    Dalloul AH; Chmouzis E; Ngo K; Fung-Leung WP
    J Immunol; 1996 Jun; 156(11):4114-9. PubMed ID: 8666777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection.
    Benichou G; Takizawa PA; Olson CA; McMillan M; Sercarz EE
    J Exp Med; 1992 Jan; 175(1):305-8. PubMed ID: 1730925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.